Prosecution Insights
Last updated: July 17, 2026
Application No. 18/574,616

HETEROCYCLIC COMPOUND AND RESISTANT HARMFUL ARTHROPOD- CONTROLLING METHOD FOR COMPOSITION CONTAINING SAME

Non-Final OA §102§103
Filed
Dec 27, 2023
Priority
Jun 29, 2021 — JP 2021-107328 +1 more
Examiner
ROBINSON, MIKHAIL O'DONNEL
Art Unit
1627
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
SUMITOMO CHEMICAL Company, Limited
OA Round
1 (Non-Final)
58%
Grant Probability
Moderate
1-2
OA Rounds
9m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allowance Rate
69 granted / 120 resolved
-2.5% vs TC avg
Strong +43% interview lift
Without
With
+42.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 4m
Avg Prosecution
43 currently pending
Career history
159
Total Applications
across all art units

Statute-Specific Performance

§101
0.9%
-39.1% vs TC avg
§103
64.5%
+24.5% vs TC avg
§102
11.7%
-28.3% vs TC avg
§112
6.8%
-33.2% vs TC avg
Black line = Tech Center average estimate • Based on career data from 120 resolved cases

Office Action

§102 §103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1-3 and 9 are rejected under 35 U.S.C. 102 (a)(1) as being anticipated by Watson et al. (US Patent No. 20130317068). Regarding claims 1-3 and 9, Watson teaches a method to control pests, such as insects and mites that cause losses in agriculture and are resistant to insecticides and miticides, by administration of a substituted 1,2,4-triazole compound represented by PNG media_image1.png 78 123 media_image1.png Greyscale (para. 0003-0005). Of the above compound Z is a pyridyl substituted with at least one halogens or alkyl, X is an alkyl, Y is PNG media_image2.png 81 86 media_image2.png Greyscale wherein R2-R4 is hydrogen, alkyl or halogen (relevant to claim 9) (para. 0009-0010). In a particular embodiments Watson teaches compounds PNG media_image3.png 141 249 media_image3.png Greyscale (relevant to claims 1-3) (Table 1). Claim 10 is rejected under 35 U.S.C. 102 (a)(1) as being anticipated by Vourloumis et al. (US Patent No. 20050075375). Regarding claim 10, Vourlouis teaches heterocyclic compounds comprising compound PNG media_image4.png 125 121 media_image4.png Greyscale PNG media_image5.png 94 343 media_image5.png Greyscale PNG media_image6.png 115 107 media_image6.png Greyscale and Ring B is PNG media_image7.png 110 132 media_image7.png Greyscale (para. 0018), which reads to claim limitation of R41 as C1-C6 carbon chain substituted with one or more halogen, R42 is H, R43, R44, R45, R47 is H and R46 as a halogen. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 1, 3-5 and 14-15 are rejected under 35 U.S.C. 103 as being unpatentable over Aoyama et al. (US Patent No. 20170223958). Regarding claims 1 and 3-5, Aoyama teaches a method for controlling harmful organisms of insecticides and acaricidal that are resistant by administration of a diarylimidazole compound of formula 1 PNG media_image8.png 88 150 media_image8.png Greyscale and formula IV PNG media_image9.png 99 145 media_image9.png Greyscale or salt thereof (para. 0006, 0020, 0091). Of the resistant insecticides Aoyama teaches hemiptera pest (relevant to claim 14) (para. 0208) and pest belonging to the Aleyrodidae and Aphididae family (relevant to claim 15) (para. 0222-0223). Of the above compounds B2 is N and B1 and B3-B4 is CH, R1 is a halogen, hydroxy, cyano, substituted or unsubstituted C1-C6 alkyl, R2 is substituted or unsubstituted C1-C6 alkyl, R3 is hydrogen or substituted or unsubstituted C1-C6 alkyl, m and n is 0, Ar is an C6-C10 aryl (relevant to claim 1) (para. 0009-0017). The above compound IV reads to Q1 of claimed invention of A1 as CH, A2 as n-methyl and A3 as n (relevant to claim 3). Therefore, it would have been obvious to someone of ordinary skill in the art at the time of filing to have developed the compound with Q2 of claimed invention by the teachings of Aoyama. One would have been motivated to do so from the teachings of Aoyama of PNG media_image9.png 99 145 media_image9.png Greyscale wherein the N with the O attachment is a positional isomer thus would possess similar properties of the claimed invention as per MPEP 2144.09 (II): Compounds which are position isomers (compounds having the same radicals in physically different positions on the same nucleus) or homologs (compounds differing regularly by the successive addition of the same chemical group, e.g., by -CH2- groups) are generally of sufficiently close structural similarity that there is a presumed expectation that such compounds possess similar properties. In re Wilder, 563 F.2d 457, 195 USPQ 426 (CCPA 1977). Claims 6-7, 11-13 and 16-18 are rejected under 35 U.S.C. 103 as being unpatentable over Fujiwara (JP 2002114783 A). Regarding claims 6-7, 11-13 and 16-18, Fujiwara teaches a method for controlling insecticides and acaricidal that are resistant comprising a composition of PNG media_image10.png 198 153 media_image10.png Greyscale mixed or used in combination with other insecticides, nematicides, acaricides, fungicides and liquid carrier (relevant to claims 11-13 and 17) (Page 1- 5). Of the above compound Fujiwara teaches R1 represents a halogen atom, R2 represents a hydrogen atom or a halogen atom, and R3- R7 each independently represents a hydrogen atom, a halogen atom, a cyano group, a nitro group, a C1-C6 alkyl group optionally substituted with a halogen atom or a C1-C6 alkoxy group optionally substituted with a halogen atom. Therefore, it would have been obvious to someone of ordinary skill in the art to have developed the compounds of claims 6-7 of claimed invention and administer it on a seed from the teachings of Fujiwara. One would have been motivated to do so from the teachings of Fujiwara of PNG media_image10.png 198 153 media_image10.png Greyscale with the above substitutions would fall into the limitations of the claim invention. One would also administer the composition on a seed as it is known in the art coating seeds before planting is a widespread practice meant to control pests on agriculture. Claim 8 is rejected under 35 U.S.C. 103 as being unpatentable over Bakker et al. (WO 2022180080 A1, published 09/01/2022 with a priority date of 02/26/2021). Regarding claim 8, Bakker teaches formula (I) PNG media_image11.png 147 234 media_image11.png Greyscale , in which in preferred embodiment A is a heteroaryl selected from quinoline, pyridine, pyrimidine, pyrazine and pyridazine substituted with one or more substituents selected from S(O)2RA wherein RA is substituted or unsubstituted C1-C6 alkyl and halogen (Pages 5-6). X and Y is C and R1-R5 is selected from H, halogen and substituted or unsubstituted C1-C6 alkyl (Page 5). Therefore, it would have been obvious to someone of ordinary skill in the art at the time of filing to have developed compound PNG media_image12.png 121 352 media_image12.png Greyscale of claimed invention with its limitations from the teachings of Bakker. One would have been motivated to do so from the teachings of Bakker of compound PNG media_image11.png 147 234 media_image11.png Greyscale with the above substitutions would fall within the claimed limitations of compound PNG media_image12.png 121 352 media_image12.png Greyscale . Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to MIKHAIL O'DONNEL ROBINSON whose telephone number is (571)270-0777. The examiner can normally be reached Monday-Friday 7:30am-5:30pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kortney Klinkel can be reached at 571-270-5239. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. MIKHAIL O'DONNEL. ROBINSON Examiner Art Unit 1627 /MIKHAIL O'DONNEL ROBINSON/Examiner, Art Unit 1627 /SARAH PIHONAK/Primary Examiner, Art Unit 1627
Read full office action

Prosecution Timeline

Dec 27, 2023
Application Filed
May 28, 2026
Non-Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12673954
BENZOFURAN COMPOUNDS AS STING AGONISTS
2y 11m to grant Granted Jul 07, 2026
Patent 12667551
RENAL FUNCTION MAINTENANCE AND PROTECTION AGENT, AND METHOD FOR EVALUATING EFFECT THEREOF
5y 6m to grant Granted Jun 30, 2026
Patent 12668581
PROCESSES FOR THE PREPARATION OF GLASDEGIB AND SALT THEREOF AND SOLID STATE FORMS OF GLASDEGIB MALEATE AND PROCESS FOR PREPARATION THEREOF
3y 11m to grant Granted Jun 30, 2026
Patent 12655154
CRYSTALLINE SOLVATED FORMS OF N-(4-(1-(2,6-DIFLUOROBENZYL)-5- ((DIMETHYLAMINO)METHYL)-3-(6-METHOXY-3-PYRIDAZINYL)-2,4-DIOXO-1,2,3,4- TETRAHYDROTHIENO[2,3-D]PYRIMIDIN-6-YL)PHENYL)-N'-METHOXYUREA
4y 2m to grant Granted Jun 16, 2026
Patent 12649725
Synthesis of small molecules inspired by Phomoxanthone A
4y 10m to grant Granted Jun 09, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
58%
Grant Probability
99%
With Interview (+42.7%)
3y 4m (~9m remaining)
Median Time to Grant
Low
PTA Risk
Based on 120 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month